Prevention of progression in monoclonal gammopathy of undetermined significance

Clin Cancer Res. 2009 Sep 15;15(18):5606-8. doi: 10.1158/1078-0432.CCR-09-1575. Epub 2009 Sep 8.

Abstract

Monoclonal gammopathy of undetermined significance (MGUS) is a common premalignant plasma cell proliferative disorder with a lifelong risk of progression to multiple myeloma. Because myeloma is an incurable malignancy, strategies to delay or prevent progression in high-risk patients are of considerable importance.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Disease Progression*
  • Humans
  • Monoclonal Gammopathy of Undetermined Significance / genetics
  • Monoclonal Gammopathy of Undetermined Significance / pathology*
  • Monoclonal Gammopathy of Undetermined Significance / prevention & control*
  • Monoclonal Gammopathy of Undetermined Significance / therapy
  • Multiple Myeloma / genetics
  • Multiple Myeloma / pathology*
  • Multiple Myeloma / prevention & control*
  • Multiple Myeloma / therapy
  • Risk Factors